D. G. Evans

Germline testing of BRCA1, BRCA2, PALB2 and CHEK2 c.1100delC in 1514 triple negative familial and isolated breast cancers from a single centre, with extended testing of ATM, RAD51C and RAD51D in over 400

E. Harkness, F. Lalloo, G. Burghel, 2023, Journal of Medical Genetics.